TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provi...
Q2 2026
Aug 3, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 27, 2026
Q4 2025
Q3 2025
Nov 5, 2025
